Adam Falchook
Neurology · Stuart, FLNPI 1780773465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by F. Hoffmann-la Roche AG at 27.4% of the total. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 13 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$80
- Teva Pharmaceuticals USA, Inc.$64
- MDD US Operations, LLC$55
- AbbVie$34
- Novartis$32
- Lilly USA, LLC$14
- plus $13 from 1 others
Across 123 payments — averaging $59,225 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$3.1M
- AbbVie$2M
- Janssen Research & Development, LLC$1.7M
- Genentech, Inc.$444K
- GSK$20K
- Novartis$158
What the payments were for
- Food & beverage$292100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 1 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| MDD US Operations, LLC | 2 | $55 |
| AbbVie | 2 | $34 |
| Novartis | 2 | $32 |
| Lilly USA, LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$292 in reported general payments places this provider in the 25th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lorazepam | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Other neurology in Stuart
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.